Viewing Study NCT03651505

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:20 AM
Ignite Modification Date: 2026-03-02 @ 3:44 PM
Study NCT ID: NCT03651505
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-31
First Post: 2018-08-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: X-linked Hypophosphatemia Disease Monitoring Program
Sponsor: Ultragenyx Pharmaceutical Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None X-linked Hypophosphatemia View
None Hypophosphatemic Rickets View
Keywords:

Keywords

Keyword Brief Keyword Text View
None X-linked Hypophosphatemia View
None Fibroblast growth factor 23 (FGF23) View
None KRN23 View
None XLH View
None Hypophosphatemia View
None Familial Hypophosphatemic Rickets View
None FGF23 View
None Crysvita View